6 employees
Aleta Biotherapeutics focuses on transforming cellular therapeutics to allow a broader spectrum of cancer indications to be targeted.
2006
Aleta Biotherapeutics raised undisclosed on July 1, 2016
Investors: Advent Life Sciences